#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14280	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2145	662.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1677	1677	T	774	T	704	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14280	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2145	662.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	875	C	805	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25956	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3623	714.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1692	1692	A	901	A	842	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25956	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3623	714.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2326	2326	C	793	C,T	735,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25956	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3623	714.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2400	2400	A	758	A	709	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25956	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3623	714.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2952	2952	C	798	C,A	739,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	4	blaTEM	861	264	100.0	blaTEM.l6.c30.ctg.1	264	1.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1962	folP	855	855	99.88	folP.l15.c4.ctg.1	1513	129.0	1	SNP	p	R229S	1	.	.	685	687	AGC	923	925	AGC	236;238;238	A;G;C	219;221;221	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	5006	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3436	145.5	0	.	p	.	0	D95A	NONSYN	283	285	GAC	586	588	GCC	179;175;176	G;C;C	159;159;160	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	5006	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3436	145.5	1	SNP	p	S91F	1	.	.	271	273	TTC	574	576	TTC	182;183;181	T;T;C	165;166;163	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1502	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1198	124.5	0	.	p	.	0	A39T	NONSYN	115	117	GCC	409	411	ACC	177;177;176	A,G;C;C	155,1;161;159	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1502	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1198	124.5	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	607	609	CAC	205;206;205	C;A;C	190;189;188	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1502	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1198	124.5	0	.	p	.	0	A127fs	FSHIFT	379	379	G	673	673	G	189	G	171	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1502	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1198	124.5	1	SNP	p	G45D	0	.	.	133	135	GGC	427	429	GGC	178;181;180	G;G,A;C	162;163,1;162	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	828	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c4.ctg.1	980	83.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4490	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3074	145.5	0	.	p	.	0	S87N	NONSYN	259	261	AGT	722	724	AAT	188;185;188	A;A;T	175;172;176	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4490	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3074	145.5	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1613	1615	GTC	195;194;194	G;T;C	184;182;183	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4490	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3074	145.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1766	1768	GCA	190;190;191	G;C;A	165;165;160	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4490	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3074	145.5	1	SNP	p	D86N	0	.	.	256	258	GAC	719	721	GAC	183;185;186	G;A;C	172;172;172	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4490	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3074	145.5	1	SNP	p	S88P	0	.	.	262	264	TCC	725	727	TCC	187;188;187	T;C;C	175;173;173	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4054	parE	1986	1986	99.95	parE.l6.c30.ctg.1	2581	156.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1500	1502	GGC	203;204;204	G;G;C	180;178;175	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3808	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2523	150.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1308	1310	GCA	201;201;203	G;C;A	185;184;186	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3808	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2523	150.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1311	1313	ATC	209;211;210	A;T,C;C	191;192,1;193	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3808	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2523	150.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1323	1325	GTG	200;199;199	G;T;G	185;183;183	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3808	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2523	150.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1323	1325	GTG	200;199;199	G;T;G	185;183;183	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3808	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2523	150.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1827	1829	ACC	187;184;182	A;C;C	163;167;166	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3808	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2523	150.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1881	1883	GCG	190;191;195	G;C,G;G	163;152,1;164	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3808	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2523	150.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1881	1883	GCG	190;191;195	G;C,G;G	163;152,1;164	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3808	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2523	150.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2004	2006	GGT	184;181;181	G;G;T	169;168;168	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3808	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2523	150.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2013	2015	GGC	175;174;172	G;G;C	161;158;156	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3808	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2523	150.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2031	2033	CCG	163;164;161	C,G;CG,CGGG;GCCC,GCCCC	110,2;101,1;99,1	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5592	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3050	182.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1669	1671	CCG	219;222;223	C;C;G	193;202;192	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1980	porA	1146	1146	99.65	porA.l6.c4.ctg.1	1725	114.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	515	515	C	148	C	132	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	T18M	NONSYN	52	54	ACG	428	430	ATG	231;233;233	A;T,C;G,A	208;208,1;204,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	I45V	NONSYN	133	135	ATT	509	511	GTT	251;253;249	G;T;T	223;226;226	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	A109V	NONSYN	325	327	GCC	701	703	GTC	232;229;231	G;T;C	199;188;206	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	N121S	NONSYN	361	363	AAC	737	739	AGC	224;224;226	A;G;C	201;202;205	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	N122K	NONSYN	364	366	AAC	740	742	AAA	224;225;224	A,G;A;A	204,1;206;206	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	767	769	TAT	229;228;230	T;A;T	210;208;209	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	N134E	NONSYN	400	402	AAT	776	778	GAG	227;225;225	G;A;G	209;207;209	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	V135F	NONSYN	403	405	GTG	779	781	TTT	227;232;231	T;T;T	206;211;209	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	G140K	NONSYN	418	420	GGA	794	796	AAA	220;220;215	A;A;A	198;199;194	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	Q143E	NONSYN	427	429	CAA	803	805	GAA	219;221;222	G;A;A	193;193;193	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	V151A	NONSYN	451	453	GTA	827	829	GCA	236;241;244	G;C;A	213;217;215	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	K207_M208insK	INS	619	619	A	995	995	A	238	A	222	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	A212S	NONSYN	634	636	GCA	1013	1015	TCA	239;242;243	T;C;A	222;228;228	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2842	porB1b	1038	1038	96.18	porB1b.l15.c4.ctg.1	1568	180.7	0	.	p	.	0	Y251fs	FSHIFT	751	751	T	1130	1130	T	199	T	190	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11646	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4696	247.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1970	1972	AAT	279;278;274	A;A;T	251;250;244	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1192	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1042	113.9	1	SNP	p	V57M	1	.	.	169	171	ATG	456	458	ATG	255;254;251	A;T;G	240;238;237	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	M177T	NONSYN	529	531	ATG	864	866	ACG	515;514;510	A;C;G	493;495;496	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	885	887	GAC	426;432;434	G;A;C	424;427;430	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	T190M	NONSYN	568	570	ACG	903	905	ATG	414;412;409	A;T;G,A	413;409;406,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	L194S	NONSYN	580	582	TTA	915	917	TCA	412;413;407	T;C;A	412;411;406	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	960	962	CAG	432;431;431	C,G;A;G	425,1;425;424	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	V216L	NONSYN	646	648	GTT	981	983	CTT	411;410;405	C;T,C;T	404;403,1;399	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1002	1004	AGT	438;443;445	A;G;T	423;428;426	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1071	1073	CCG	630;629;631	C;C;G	586;586;586	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1173	1175	TCG	648;643;651	T;C;G	596;590;595	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1344	1346	AAA	358;350;341	A;A;A	340;337;329	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1347	1349	AAG	333;327;320	A;A;G,T	324;318;311,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1362	1364	CAC	281;279;271	C;A,G;C,A	278;259,1;270,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1401	1403	GAA	241;239;241	G;A;A	240;239;240	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1479	1481	ACG	203;205;204	A;C;G	200;204;203	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1530	1532	ATT	300;299;301	A,T;T;T	277,1;276;279	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1533	1535	AGT	301;303;303	A;G;T	279;281;279	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1572	1574	CTA	336;337;338	C;T;A	308;307;308	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1614	1616	AAT	223;225;228	A;A;T	212;214;217	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1683	1685	TCA	338;339;342	T;C,A;A	317;317,1;317	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1707	1709	ATG	360;364;363	A;T;G	346;349;349	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2001	2003	ACC	776;774;771	A;C;C	705;711;705	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	12934	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2548	505.6	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2097	2099	GAA	760;761;759	G,A;A;A	706,1;712;711	.	Tetracycline resistance
